SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,762 | -99.6% | 85,600 | +574.0% | 0.00% | +200.0% |
| Q3 2022 | $497,000 | -64.6% | 12,700 | -70.7% | 0.00% | -50.0% |
| Q2 2022 | $1,402,000 | -88.2% | 43,400 | -84.8% | 0.00% | -80.0% |
| Q2 2020 | $11,884,000 | -44.6% | 285,800 | -61.7% | 0.01% | -52.4% |
| Q1 2020 | $21,458,000 | +168.8% | 747,132 | +575.6% | 0.02% | +250.0% |
| Q4 2019 | $7,984,000 | +1916.2% | 110,591 | +3849.7% | 0.01% | – |
| Q3 2018 | $396,000 | -99.5% | 2,800 | -99.4% | 0.00% | -100.0% |
| Q2 2018 | $73,126,000 | +55.5% | 458,700 | +57.1% | 0.04% | -21.6% |
| Q1 2018 | $47,032,000 | +1145.2% | 292,000 | +1173.4% | 0.05% | +1175.0% |
| Q4 2017 | $3,777,000 | +576.9% | 22,931 | +106.6% | 0.00% | +300.0% |
| Q1 2015 | $558,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |